Leaderboards/Retinopathy of Prematurity Studies

Retinopathy of Prematurity Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Thanh-Tin P. Nguyen
Oregon Health & Science University
2
Kou Liu
Beijing Tongren Hospital
3
Valeriia Klymenko
Rutgers, The State University of New Jersey
4
N. de las Rivas Ramírez
Hospital San Pedro
5
Larissa I. van der Windt
Amsterdam University Medical Centers
6
Shivakumar K Reddy
Manipal Academy of Higher Education
7
Ssu‐Hsien Lee
Tzu Chi University
8
Koon Hwee Ang
Agency for Science, Technology and Research
9
Salma El Emrani
Leiden University Medical Center
10
Francisco Altamirano
Boston Children's Hospital

Papers

1
Publication in Frontiers in Endocrinology (2024) [34 citations, W4399691331]
Frontiers in Endocrinology|2024
34 cit.
2
Publication in American Journal of Ophthalmology (2024) [12 citations, W4390887410]
American Journal of Ophthalmology|2024
12 cit.
3
Publication in Ophthalmology (2025) [11 citations, W4406160000]
Ophthalmology|2025
11 cit.
4
Publication in Investigative Ophthalmology & Visual Science (2024) [5 citations, W4402222944]
Investigative Ophthalmology & Visual Science|2024
5 cit.
5
Publication in Acta Ophthalmologica (2025) [5 citations, W4407987628]
Acta Ophthalmologica|2025
5 cit.
6
Publication in Archives of Disease in Childhood Fetal & Neonatal (2025) [3 citations, W4406861963]
Archives of Disease in Childhood Fetal & Neonatal|2025
3 cit.
7
Publication in Early Human Development (2025) [3 citations, W4408173788]
Early Human Development|2025
3 cit.
8
Publication in Journal of American Association for Pediatric Ophthalmology and Strabismus (2025) [3 citations, W4408224948]
Journal of American Association for Pediatric Ophthalmology and Strabismus|2025
3 cit.
9
Publication in Nature Communications (2025) [3 citations, W4410621400]
Nature Communications|2025
3 cit.
10
Publication in BMC Ophthalmology (2024) [2 citations, W4403473643]
BMC Ophthalmology|2024
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Cristina Montero-Mendoza
Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes
2
Frédérick A. Mallette
Hôpital Maisonneuve-Rosemont
3
Yusuf Koçluk
Unknown
4
Jie Zhong
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
5
Emmanuel Chang
Baylor College of Medicine
6
Jeremy N. Kay
Duke University
7
Maryam Firdous
Dar Al-Shifa Hospital
8
Songfu Feng
Zhujiang Hospital
9
Qingguo Xu
Virginia Commonwealth University
10
Nicole E. Faster
Unknown

Papers

1
Effect of phacoemulsification on intraocular pressure in glaucoma patients
Journal of Shifa Tameer-e-Millat University|2023
137 cit.
2
Standards for Levels of Neonatal Care: II, III, and IV
PEDIATRICS|2023
123 cit.
3
Federated Learning for Multicenter Collaboration in Ophthalmology
Ophthalmology Retina|2022
41 cit.
4
Federated Learning for Multicenter Collaboration in Ophthalmology
Ophthalmology Retina|2022
35 cit.
5
Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity
Ophthalmology|2022
25 cit.
6
Association of Biomarker-Based Artificial Intelligence With Risk of Racial Bias in Retinal Images
JAMA Ophthalmology|2023
21 cit.
7
Six-month effective treatment of corneal graft rejection
Science Advances|2023
20 cit.
8
pH-Responsive Mucus-Penetrating Nanoparticles for Enhanced Cellular Internalization by Local Administration in Vaginal Tissue
ACS Macro Letters|2023
19 cit.
9
CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax
Cell Reports|2023
13 cit.
10
Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury
Experimental Eye Research|2024
13 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Lois E. H. Smith
Boston Children's Hospital
2
Eli Keshet
Hebrew University of Jerusalem
3
Michael F. Chiang
United States National Library of Medicine
4
Ann Hellström
Sahlgrenska University Hospital
5
Allen Foster
Tel Aviv University
6
Robin R. Ali
Cell and Gene Therapy Catapult
7
David K. Wallace
Indiana University Health
8
Patrìcia A. D'Amore
Massachusetts Eye and Ear Infirmary
9
Alice Z. Chuang
The University of Texas Health Science Center at Houston
10
Thomas W. Gardner
University of Michigan

Papers

1
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Nature|1992
4.6k cit.
2
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Nature|1998
2.5k cit.
3
Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
New England Journal of Medicine|2008
1.9k cit.
4
Oxygen-induced retinopathy in the mouse.
PubMed|1994
1.6k cit.
5
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
Nature Medicine|1995
1.6k cit.
6
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
New England Journal of Medicine|2011
1.5k cit.
7
The International Classification of Retinopathy of Prematurity Revisited : An International Committee for the Classification of Retinopathy of Prematurity
Archives of Ophthalmology|2005
1.4k cit.
8
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.
Journal of Clinical Investigation|1998
1.3k cit.
9
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Proceedings of the National Academy of Sciences|1995
1.3k cit.
10
Time Series Analysis: Univariate and Multivariate Methods
Technometrics|1991
1.3k cit.

Reagents for Retinopathy of Prematurity Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

HSF1 Antibody

#4356$135,314
View Evidence →
Cell Signaling TechnologyEvidence 69

Helios (D8W4X) Rabbit Monoclonal Antibody (mFluor™ UV375 Conjugate)

#16012$465
View Evidence →
Cell Signaling Technology

CD82 (D7G6H) Rabbit Monoclonal Antibody

#12439$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

FAM96B (D4V9Z) Rabbit Monoclonal Antibody

Cited in 6 papers
#86302$161,351
View Evidence →
Cell Signaling TechnologyEvidence 63

Rabbit (DA1E) Monoclonal Antibody IgG Isotype Control (mFluor™ Violet 510 Conjugate)

#54005$176
View Evidence →
Cell Signaling TechnologyEvidence 65

Sortilin Antibody

#20681$317
View Evidence →